Combination pharmacotherapy in the treatment of experimental cardiac arrest

American Journal of Emergency Medicine

Volumn 27, Issue 6, 2009, Pages 651-659

  Xanthos, Theodoros ^a   Bassiakou, Eleni ^a   Koudouna, Eleni ^a   Rokas, Georgios ^a   Goulas, Sotirios ^a   Dontas, Ismene ^a   Kouskouni, Evaggelia ^a   Perrea, Despina ^a   Papadimitriou, Lila ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATENOLOL; LEVOSIMENDAN; NEURON SPECIFIC ENOLASE; PLACEBO; PROTEIN S 100; TROPONIN I;

ALERTNESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; EXPERIMENTAL MODEL; EXPERIMENTAL PIG; FEMALE; HEART ARREST; HEART FUNCTION; HEART OUTPUT; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; PIGLET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATENOLOL; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EPINEPHRINE; HEART ARREST; HYDRAZONES; LACTIC ACID; PHOSPHOPYRUVATE HYDRATASE; PYRIDAZINES; S100 PROTEINS; SWINE; TROPONIN I;

EID: 67649990599     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.05.004     Document Type: Article

References (28)

1. Nolan J.P., Deakin C.D., Soar J., et al. European resuscitation council. Guidelines for resuscitation 2005: Section 4. Adult advanced life support. Resuscitation 67 (2005) S39-S86
2. Killingsworth C.R., Wei C.C., Dell'Italia L.J., et al. Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival following prolonged ventricular fibrillation. Circulation 109 (2004) 2469-2474
3. Cammarata G., Weil M.H., Sun S., et al. Beta1-adrenergic blockade during cardiopulmonary resuscitation improves survival. Crit Care Med 32 (2004) S440-S443
4. Ukkonen H., Saraste M., Akkila J., et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68 (2000) 522-531
5. Tassani P., Schad H., Heimisch W., et al. Effect of the calcium sensitizer levosimendan on the performance of ischaemic myocardium in anaesthetised pigs. Cardiovasc Drugs Ther 16 (2002) 435-444
6. Huang L., Weil M.H., Sun S., et al. Levosimendan improves postresuscitation outcomes in a rat model of CPR. J Lab Clin Med 146 (2005) 256-261
7. Pfeifer R., Borner A., Krack A., et al. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation 65 (2004) 49-55
8. Schoerkhuber W., Kittler H., Sterz F., et al. Time course of serum neuron-specific enolase: a predictor of neurological outcome in patients resuscitated from cardiac arrest. Stroke 30 (1999) 1598-1603
9. Bassiakou E., Xanthos T., Koudouna E., et al. Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation. Am J Emerg Med 26 (2008) 578-584
10. Koudouna E., Xanthos T., Bassiakou E., et al. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Acta Anaesthesiol Scand 51 (2007) 1123-1129
11. Tang W., Weil M.H., Sun S., et al. The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol 34 (1999) 815-822
12. 2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation 108 (2003) 2716-2721
13. Xanthos T., Bassiakou E., Koudouna E., et al. Baseline hemodynamics in anesthetized Landrace-Large White swine: reference values for research in cardiac arrest and cardiopulmonary resuscitation models. J Am Assoc Lab Anim Sci 46 (2007) 21-25
14. Checchia P., Borensztajn J., and Shulman S.T. Circulating cardiac troponin I levels in Kawasaki disease. Pediatr Cardiol 22 (2001) 102-106
15. Walker M.J., Curtis M.J., Hearse D.J., et al. The Lamberth Convention: guidelines for the study of arrhythmias in ischemia, infarction and reperfusion. Cardiovasc Res 22 (1988) 447-455
16. Endoh M. Mechanism of action of Ca sensitizers-update 2001. Cardiovasc Drugs Ther 15 (2001) 397-403
17. Janssen P.M., Datz N., Zeitz O., and Hasenfuss G. Levosimendan improves diastolic and systolic function in failing myocardium. Eur J Pharmacol 404 (2000) 191-199
18. Lilleberg J., Ylolen V., Lehtonen L., and Lauri Toivonen L. The calcium sensitizer levosimendan and cardiac arrythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J 38 (2004) 80-84
19. Toller W., Wolkart G., Stranz C., et al. Contractile action of levosimendan and epinephrine during acidosis. Eur J Pharmacol 507 (2005) 199-209
20. Krummikl J.J., Toller W.G., Prener G., et al. Beneficial outcome after prostaglandin induced post-partum cardiac arrest using levosimendan and extracorporeal membrane oxygenation. Acta Anaestesiol Scand 50 (2006) 768-770
21. Huang L., Weil M.H., Tang W., et al. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med 33 (2005) 487-491
22. Tyson G.W., Teasdale G.M., Graham D.I., et al. Focal cerebral ischemia in the rat: topography of hemodynamic and histopathologic changes. Ann Neurol 15 (1984) 559-567
23. Bell B.A., Symon L., and Branston N.M. CBF and time thresholds for the formation of ischemic cerebral edema and effect of reperfusion in baboons. J Neurosurg 62 (1985) 31-41
24. Nathanson J.A. Cerebral microvessels contain a beta2- adrenergic receptor. Life Sci 26 (1980) 1793-1799
25. Brown C.G., Birinyi F., Werman H.A., et al. The comparative effects of epinephrine versus phenylephrine on regional cerebral blood flow during cardiopulmonary resuscitation. Resuscitation 14 (1986) 171-183
26. Wang J., Weil M.H., Tang W., et al. Levosimendan improves postresuscitation myocardial dysfunction after beta-adrenergic blockade. J Lab Clin Med 146 (2005) 179-183
27. Haikala H., Kaheinen P., Levijoki J., et al. The role of Camp- and Cgmp-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res 34 (1997) 536-546
28. Lehtonen L., and Sundberg S. The contractility enhancing effect of the calcium sensitizer levosimendan is not attenuated by carvedilol in healthy subjects. Eur J Clin Pharmacol 58 (2002) 449-452